To counteract this impact of BMP4, bladder cancer cells downregulate the BMP type II receptor (BMPR2) on their surface through the secretion of miR-21, thereby rendering the tumor resistant to the inhibitory effects of surrounding BMP (82). This evidence concerns the gene BMP4 and urinary bladder carcinoma.